-
S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer
10 Apr 2025 14:18 GMT
… drug is now FDA-approved for any tumor type … Inhibition for the Treatment of Patients … Trial
Antibody-Drug Conjugates as Targeted Therapy for Treating Gynecologic Cancers … Ixabepilone/Carboplatin/Bevacizumab in Advanced/Recurrent Endometrial Cancer
-
Construction and Evaluation of BAL-PTX Co-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs
30 Jul 2024 09:43 GMT
… and medications, thereby enhancing drug delivery to cancer cells. … treatment of lung cancer.
Abbreviations
API, Active pharmaceutical ingredients … small cell lung cancer: tumor heterogeneity, diagnosis, therapy … per week or ixabepilone with bevacizumab as …
-
Ixabepilone Combo Improves PFS/OS in Platinum-Resistant Ovarian Cancer
28 Mar 2024 20:39 GMT
… of Maryland Medical System in Baltimore.
The trial was designed … chemotherapy-resistant ovarian cancer.2
The trial’s end points … ixabepilone on days 1, 8, and 15 of a 28-day treatment … Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for …
-
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
21 Mar 2024 04:56 GMT
… plus temsirolimus or ixabepilone, carboplatin and bevacizumab … and tumor tissue targeting (drug accumulation in tumor tissue … Treatment for Advanced Endometrial Cancer: the Phase III DUO-E Trial … Engineering of Medicinal Chemistry for Cancer Therapy: recent …
-
Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges
23 Feb 2024 13:20 GMT
… al164 proposed a pharmaceutical-organic-inorganic self- … drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment. Cancer … barriers to drug delivery. Nat Biotechnol. 2015;33 … per week or ixabepilone with bevacizumab as …
-
Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic
05 Dec 2023 12:30 GMT
… pharmaceutical company developing novel oncology therapeutics together with drug … in renal cancer; and IXEMPRA® (Ixabepilone), a microtubule … tumor biology filters and prior clinical trial outcomes … clinical outcome from drug treatment in cancer patients in …
-
Wyn Drabble: Pharmaceutical nomenclature – is there a remedy?
20 Sep 2023 02:01 GMT
… Drabble asks why most medication has such complicated … company.
Cisplatin, a chemotherapy cancer drug, has the word splat … Among them were idarucizumab, ixabepilone and eszopiclone (see glossary). … packaging of so many pharmaceuticals with their almost …
-
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
24 Jul 2023 10:00 GMT
… Corporate Controller at Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT … 3 in renal cancer; and IXEMPRA® (Ixabepilone), a microtubule … clinical tumor biology filters and prior clinical trial outcomes. … clinical outcome from drug treatment in cancer patients in 37 …
-
Initial Data from Allarity’s Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients
05 Jul 2023 13:45 GMT
… pharmaceutical company developing novel oncology therapeutics together with drug … in renal cancer; and IXEMPRA® (Ixabepilone), a microtubule … tumor biology filters and prior clinical trial outcomes … clinical outcome from drug treatment in cancer patients in …
-
Allarity Therapeutics Doses First Patient in Phase 1b Clinical Trial Evaluating Dovitinib and Stenoparib Combination in Advanced Solid Tumors
20 Mar 2023 10:00 GMT
… pharmaceutical company developing novel oncology therapeutics together with drug … tumor biology filters and prior clinical trial outcomes … clinical outcome from drug treatment in cancer patients in … renal cancer through Phase 3; and IXEMPRA® (Ixabepilone), …
About
© 1995-2025